Robert J. Deans
Corporate Officer/Principal bij Kent State University (Ohio)
Profiel
Robert J.
Deans is currently the Chairman of Regenerative Medicine at Kent State University.
Previously, he held positions as Director of Research & Development at Baxter International, Vice President of Research at Osiris Therapeutics, and Senior Vice President of Regenerative Medicine at Athersys, Inc. He also served as Senior Vice President of Regenerative Medicine at BTHC VI, Inc. and Executive Vice President of Regenerative Medicine at Athersys, Inc. Deans received his undergraduate degree from Massachusetts Institute of Technology and his doctorate from the University of Michigan.
Actieve functies van Robert J. Deans
| Bedrijven | Functie | Begin |
|---|---|---|
| Kent State University (Ohio) | Corporate Officer/Principal | - |
Eerdere bekende functies van Robert J. Deans
| Bedrijven | Functie | Einde |
|---|---|---|
| BTHC VI, Inc. | Corporate Officer/Principal | 06-09-2007 |
Athersys, Inc. /Old/
 Athersys, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Athersys, Inc. manufactures & markets pharmaceutical products and is engaged in the development and commercialization of therapeutic products to treat significant and life-threatening diseases. The company has three primary focus areas, which include: regenerative medicine (applying the MultiStem, cell therapy platform), medicinal chemistry & pharmacology genomics. It was founded in December 1995 and is headquartered at Cleveland, OH. | Corporate Officer/Principal | 01-06-2007 |
| OSIRIS THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2001 |
| BAXTER INTERNATIONAL INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-1998 |
| ATHERSYS, INC. | Corporate Officer/Principal | - |
Opleiding van Robert J. Deans
| Massachusetts Institute of Technology | Undergraduate Degree |
| University of Michigan | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BAXTER INTERNATIONAL INC. | Health Technology |
| ATHERSYS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
| BTHC VI, Inc. | Finance |
Osiris Therapeutics, Inc.
 Osiris Therapeutics, Inc. BiotechnologyHealth Technology Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD. | Health Technology |
Athersys, Inc. /Old/
Athersys, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Athersys, Inc. manufactures & markets pharmaceutical products and is engaged in the development and commercialization of therapeutic products to treat significant and life-threatening diseases. The company has three primary focus areas, which include: regenerative medicine (applying the MultiStem, cell therapy platform), medicinal chemistry & pharmacology genomics. It was founded in December 1995 and is headquartered at Cleveland, OH. | Health Technology |